NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ZEEKR Intelligent Technology Holding Limited (“Zeekr” or the “Company”) (NYSE: ZK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zeekr and certain of its officers and/or directors […]

(Other OTC:GELYF),(Other OTC:GELYY), NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Geely Automobile Holdings Limited (“Geely” or the “Company”) (OTCMKTS: GELYF; GELYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Geely and certain of its

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ZEEKR Intelligent Technology Holding Limited – ZK GlobeNewswire August 29, 2025 NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ZEEKR Intelligent Technology Holding Limited (“Zeekr” or the “Company”) (NYSE: ZK). Such investors are

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geely Automobile Holdings Limited – GELYF; GELYY GlobeNewswire August 29, 2025 NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Geely Automobile Holdings Limited (“Geely” or the “Company”) (OTCMKTS: GELYF; GELYY). Such investors are

Sparkvia AI to Launch SPARK Token on XRP Ledger September 1, Unlocking Governance and New Features for Creators GlobeNewswire August 29, 2025 VALLETTA, Malta, Aug. 29, 2025 (GLOBE NEWSWIRE) — Sparkvia AI, an AI-powered writing platform built on the XRP Ledger, announced that it will launch its native SPARK token (SPK) on September 1, 2025.

(NYSE:EHC), NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Encompass and certain of its officers and/or directors have

(NYSE:GSK), NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors have engaged

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation – EHC GlobeNewswire August 29, 2025 NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK GlobeNewswire August 29, 2025 NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at

The globalPharmaceutical Contract Manufacturing Market, valued at US$193.99 billion in 2024, stood at US$209.90 billion in 2025 and is projected to advance at a resilient CAGR of 8.2% from 2025 to 2030, culminating in a forecasted valuation of US$311.95 billion by the end of the period. This is mainly due to the high demand for